Immutep, Monash win A$652,248 ARC grant for LAG-3 research project
IMMP•Immutep and Monash University won A$652,248 in ARC funding over three years for LAG-3 research, including evaluation of Immutep’s IMP761 agonist antibody.
1. Grant supports research
The Monash-led project will study LAG-3 immune regulation and evaluate Immutep’s IMP761 agonist antibody. Immutep will also contribute funding from its research budget and said the amounts are not material.
